|Bid||282.25 x 200|
|Ask||282.41 x 200|
|Day's Range||280.02 - 282.79|
|52 Week Range||244.28 - 333.65|
|PE Ratio (TTM)||17.69|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Here are the activist investor's next potential targets.
Roche, Celgene and Novartis could change the multiple sclerosis landscape, a sector now dominated by Biogen.
We analyzed publicly traded companies based in the Bay State to identify the best stock in Massachusetts to buy now.